Home › Funds › Palo Alto Investors LP › NVCR

Palo Alto Investors LP position in NVCR

NOVOCURE LTD · Health Care

Palo Alto Investors LP reported holding 1,209,774 shares of NVCR (NOVOCURE LTD) in its Q3 2026 13F filing — a position valued at US$19.3M, representing 2.87% of its reported portfolio and ranking #14 among its reported holdings. Palo Alto Investors LP has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.21M sh
Reported value held$19.30M
Portfolio Weight2.87%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's NVCR position evolved

Palo Alto Investors LP first disclosed a stake in NVCR in Q3 2023 at 660,275 shares (US$10.7M). The position peaked in Q4 2024 at 814,191 shares, worth US$24.3M. Across 13 filings, Palo Alto Investors LP increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,209,774 shares valued at US$19.3M — a reduction of -70,665 shares quarter over quarter.. Notable position changes include a 37% increase in Q4 2024 (shares fell 40% over the following quarter), a 31% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 660.27K $10.66M New
Q4 2023 561.91K $8.39M Reduce
Q1 2024 561.91K $8.78M Hold
Q2 2024 561.91K $9.63M Hold
Q3 2024 593.54K $9.28M Add
Q4 2024 814.19K $24.26M Add
Q1 2025 1.00M $17.86M Add
Q2 2025 962.40K $17.13M Reduce
Q3 2025 1.26M $16.23M Add
Q4 2025 1.30M $16.80M Add
Q1 2026 1.28M $13.96M Reduce
Q2 2026 1.28M $19.40M Hold
Q3 2026 1.21M $19.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVCR and 13F data

NVCR (NOVOCURE LTD) is a Health Care company. 26 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.3M), C WorldWide Group Holding A/S (US$15.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVCR

All NVCR fund holders →

FAQ

How long has Palo Alto Investors LP held NVCR?

Palo Alto Investors LP has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palo Alto Investors LP's current position in NVCR?

As of Q3 2026, Palo Alto Investors LP holds 1.21M shares of NVCR (NOVOCURE LTD), valued at $19.30M, representing 2.87% of its reported portfolio and ranking #14.

Has Palo Alto Investors LP been buying or selling NVCR?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in NVCR. The position peaked in Q4 2024 at 814.19K shares.

Which other funds hold NVCR?

Other major institutional holders of NVCR include Soleus Capital Management, L.P., C WorldWide Group Holding A/S, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.